Table 2 Results from selected markers to represent each introgression. Multiple disease resistant donor line (Donor), code name of NIL parent carrying target introgression and crossed to H100 to form F2:3 families for validation, marker, chromosome (Chr) and genetic bin, genetic position (cM) based on the IBM4 genetic map, trait and additive effect estimate (Embedded Image) previously associated with the marker (Lopez-Zuniga 2016), disease, additive effect (Embedded Image), dominance effect (Embedded Image), and trait(s) for which QTL effect was validated by this study. Non-significant dominance effect are denoted as NS. All reported marker effects are significant at P = 0.05
QTL effect detected in previous studySignificant QTL effects detected in current study
DonorDRIL parent codeMarkerChr/BincMTraitEmbedded ImageDiseaseEmbedded ImageEmbedded ImageTrait(s) with validated QTL effect
Ki3DRIL32.090PHM3457-62.0596.4MDR0.39GLS0.18NSMDR
NLB0.07NS
DRIL32.090PZA00379-28.0359.5MDR, SLB0.27, 0.28SLB0.16NSMDR, SLB
NLB0.10NS
DRIL32.095PZA01886-19.04114.7MDR, SLB0.50, 0.29SLB0.30NSSLB
DRIL32.134PZA00485-22.0599.1GLS0.28NS
DRIL32.134PHM4757-148.0389.8MDR, GLS, NLB0.24, 0.16, -2.73NLB0.13NSNLB
DRIL32.191PHM4495-149.0359.0MDR, SLB0.36, 0.25NLB0.05NS
NC262DRIL52.055PZA03577-12.07195.7MDR0.36SLB−0.19NS
DRIL52.055PZA00060-29.04114.5MDR0.33SLB0.18NSMDR
NLB0.03NS
DRIL52.268PZA03577-12.07195.7MDR0.36GLS0.13NS
DRIL52.268PHM4757-148.0398.8GLS0.35GLS−0.11NS
NC304DRIL62.030PHM13420-113.0492.1MDR, GLS0.54, 0.17GLS0.32NSGLS
NC304DRIL62.078PHM9635-304.0596.0GLS0.17GLS0.26NSGLS
NLB0.05NS
NC304DRIL62.078PZA02209-25.04124.0MDR0.25GLS0.15NSMDR
SLB0.14NS
NLB0.06NS
NC304DRIL62.156PHM13420-113.0492.1MDR, GLS0.54, 0.17GLS0.27NSMDR, GLS
SLB0.43NS
NLB0.080.14
NC344DRIL72.061PHM14412-42.05127.4MDR, GLS0.30, 0.16GLS0.270.54GLS
NC344DRIL72.061PZA00667-13.0496.7MDR0.35SLB0.21NSMDR
NLB0.07NS
NC344DRIL72.232PHM4586-122.0579.3GLS0.14NLB−0.07NS